Literature DB >> 23596095

Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes.

Karin E Johnson1, Sarah J Beaton, Susan E Andrade, T Craig Cheetham, Pamela E Scott, Tarek A Hammad, Inna Dashevsky, William O Cooper, Robert L Davis, Pamala A Pawloski, Marsha A Raebel, David H Smith, Sengwee Toh, De-Kun Li, Katherine Haffenreffer, Sascha Dublin.   

Abstract

PURPOSE: Research on medication safety in pregnancy often utilizes health plan and birth certificate records. This study discusses methods used to link mothers with infants, a crucial step in such research.
METHODS: We describe how eight sites participating in the Medication Exposure in Pregnancy Risk Evaluation Program created linkages between deliveries, infants and birth certificates for the 2001-2007 birth cohorts. We describe linkage rates across sites, and for two sites, we compare the characteristics of populations linked using different methods.
RESULTS: Of 299,260 deliveries, 256,563 (86%; range by site, 74-99%) could be linked to infants using a deterministic algorithm. At two sites, using birth certificate data to augment mother-infant linkage increased the representation of mothers who were Hispanic or non-White, younger, Medicaid recipients, or had low educational level. A total of 236,460 (92%; range by site, 82-100%) deliveries could be linked to a birth certificate.
CONCLUSIONS: Tailored approaches enabled linking most deliveries to infants and to birth certificates, even when data systems differed. The methods used may affect the composition of the population identified. Linkages established with such methods can support sound pharmacoepidemiology studies of maternal drug exposure outside the context of a formal registry.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Medicaid; birth certificates; medical record linkage; pharmacoepidemiology; pregnancy outcome/epidemiology

Mesh:

Year:  2013        PMID: 23596095      PMCID: PMC3707923          DOI: 10.1002/pds.3443

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  18 in total

1.  Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data.

Authors:  Marsha A Raebel; Jennifer L Ellis; Susan E Andrade
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-12       Impact factor: 2.890

2.  Cesarean delivery among women with low-risk pregnancies: a comparison of birth certificates and hospital discharge data.

Authors:  Emily B Kahn; Cynthia J Berg; William M Callaghan
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

3.  Design of a national distributed health data network.

Authors:  Judith C Maro; Richard Platt; John H Holmes; Brian L Strom; Sean Hennessy; Ross Lazarus; Jeffrey S Brown
Journal:  Ann Intern Med       Date:  2009-07-28       Impact factor: 25.391

4.  Characteristics of unmatched maternal and baby records in linked birth records and hospital discharge data.

Authors:  Jane B Ford; Christine L Roberts; Lee K Taylor
Journal:  Paediatr Perinat Epidemiol       Date:  2006-07       Impact factor: 3.980

5.  Methodological issues in evaluating expanded Medicaid coverage for pregnant women.

Authors:  J M Piper; W A Ray; M R Griffin; R Fought; J R Daughtery; E Mitchel
Journal:  Am J Epidemiol       Date:  1990-09       Impact factor: 4.897

6.  Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.

Authors:  Susan E Andrade; Heather McPhillips; David Loren; Marsha A Raebel; Kimberly Lane; James Livingston; Denise M Boudreau; David H Smith; Robert L Davis; Mary E Willy; Richard Platt
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-03       Impact factor: 2.890

7.  Outpatient use of cardiovascular drugs during pregnancy.

Authors:  Susan E Andrade; Marsha A Raebel; Jeffrey Brown; Kimberly Lane; James Livingston; Denise Boudreau; Sharon J Rolnick; Douglas Roblin; David H Smith; Gerald J Dal Pan; Pamela E Scott; Richard Platt
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-03       Impact factor: 2.890

8.  Prescription drug use in pregnancy.

Authors:  Susan E Andrade; Jerry H Gurwitz; Robert L Davis; K Arnold Chan; Jonathan A Finkelstein; Kris Fortman; Heather McPhillips; Marsha A Raebel; Douglas Roblin; David H Smith; Marianne Ulcickas Yood; Abraham N Morse; Richard Platt
Journal:  Am J Obstet Gynecol       Date:  2004-08       Impact factor: 8.661

Review 9.  Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Authors:  Robert L Davis; David Rubanowice; Heather McPhillips; Marsha A Raebel; Susan E Andrade; David Smith; Marianne Ulcickas Yood; Richard Platt
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-10       Impact factor: 2.890

10.  Use of antidepressant medications during pregnancy: a multisite study.

Authors:  Susan E Andrade; Marsha A Raebel; Jeffrey Brown; Kimberly Lane; James Livingston; Denise Boudreau; Sharon J Rolnick; Douglas Roblin; David H Smith; Mary E Willy; Judy A Staffa; Richard Platt
Journal:  Am J Obstet Gynecol       Date:  2007-10-01       Impact factor: 8.661

View more
  9 in total

1.  Trends in elective labor induction for six United States health plans, 2001-2007.

Authors:  Sascha Dublin; Karin E Johnson; Rod L Walker; Lyndsay A Avalos; Susan E Andrade; Sarah J Beaton; Robert L Davis; Lisa J Herrinton; Pamala A Pawloski; Marsha A Raebel; David H Smith; Sengwee Toh; Aaron B Caughey
Journal:  J Womens Health (Larchmt)       Date:  2014-10-20       Impact factor: 2.681

2.  Power in numbers.

Authors:  Evelyne Vinet; Eliza F Chakravarty; Megan E B Clowse
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

3.  Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.

Authors:  Sarah C MacDonald; Jacqueline M Cohen; Alice Panchaud; Thomas F McElrath; Krista F Huybrechts; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-07-22       Impact factor: 2.890

Review 4.  Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy.

Authors:  Krista F Huybrechts; Brian T Bateman; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-05-10       Impact factor: 2.890

5.  Single-stage versus multi-stage pull-through for Hirschsprung's disease: practice trends and outcomes in infants.

Authors:  Jason P Sulkowski; Jennifer N Cooper; Anthony Congeni; Erik G Pearson; Benedict C Nwomeh; Edward J Doolin; Martin L Blakely; Peter C Minneci; Katherine J Deans
Journal:  J Pediatr Surg       Date:  2014-07-10       Impact factor: 2.545

6.  Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database.

Authors:  Caitlin A Knox; Christian Hampp; Kristin Palmsten; Yanmin Zhu; Soko Setoguchi; Babette Brumback; Richard Segal; Almut G Winterstein
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-07-09       Impact factor: 2.890

7.  Linking Data for Mothers and Babies in De-Identified Electronic Health Data.

Authors:  Katie Harron; Ruth Gilbert; David Cromwell; Jan van der Meulen
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

8.  The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort.

Authors:  Chun R Chao; Lawrence H Kushi; Hazel B Nichols; Chris D Baggett; Stephanie M Engel; Darios Getahun; Chelsea Anderson; Nancy T Cannizzaro; Laura Green; Parul Gupta; Cecile A Laurent; Paul C Lin; Clare Meernik; Lisa M Moy; Ethan Wantman; Lanfang Xu; Marilyn L Kwan; Jennifer E Mersereau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-02-22       Impact factor: 4.090

Review 9.  Administrative Claims Data Versus Augmented Pregnancy Data for the Study of Pharmaceutical Treatments in Pregnancy.

Authors:  Susan E Andrade; Anick Bérard; Hedvig M E Nordeng; Mollie E Wood; Marleen M H J van Gelder; Sengwee Toh
Journal:  Curr Epidemiol Rep       Date:  2017-04-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.